|
Welcure Drugs & Pharmaceuticals Ltd.
|
HALFYEARLY RESULTS
|
|
|
You can view the
Halfyearly Results
for the last 5 years.
|
Market Cap. (Rs.)
|
61.80 Cr.
|
P/BV
|
0.49
|
Book Value (Rs.)
|
1.02
|
|
52 Week High/Low (Rs.)
|
1/0
|
FV/ML
|
1/1
|
P/E(X)
|
28.57
|
|
Bookclosure
|
16/10/2025
|
EPS (Rs.)
|
0.02
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 365.54 | 30.05 | 24.55 | 0.00 | 0.00 |
| Total Income From Operations | 365.54 | 30.05 | 24.55 | 0.00 | 0.00 |
| Purchase of Traded Goods | 322.85 | 147.62 | 164.03 | 0.00 | 0.00 |
| Increase/Decrease in Stocks | 0.00 | -122.53 | -143.52 | 0.00 | 0.00 |
| Employees Cost | 0.05 | 0.36 | 0.15 | 0.06 | 0.03 |
| Depreciation | 0.01 | 0.01 | 0.01 | 0.03 | 0.01 |
| Other Expenses | 0.13 | 3.03 | 2.40 | 0.05 | 0.09 |
| Total Expenses | 323.04 | 28.51 | 23.06 | 0.14 | 0.13 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 42.50 | 1.54 | 1.49 | -0.14 | -0.13 |
| Other Income | 0.00 | 1.91 | 0.00 | 0.09 | 0.00 |
| P/L Before Interest, Excpt. Items & Tax | 42.50 | 3.45 | 1.49 | -0.05 | -0.13 |
| P/L Before Exceptional Items & Tax | 42.50 | 3.45 | 1.49 | -0.05 | -0.13 |
| P/L Before Tax | 42.50 | 3.45 | 1.49 | -0.05 | -0.13 |
| Tax | 10.70 | 0.50 | 0.00 | 0.00 | 0.00 |
| P/L After Tax from Ordinary Activities | 31.80 | 2.95 | 1.49 | -0.05 | -0.13 |
| Net Profit/Loss For the Period | 31.80 | 2.95 | 1.49 | -0.05 | -0.13 |
| | | | | | |
| Equity Share Capital | 112.44 | 112.44 | 13.44 | 13.44 | 13.44 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 2.83 | 0.02 | 0.13 | (.00) | -0.01 |
| Diluted EPS (Rs.) | 2.83 | 0.03 | 0.13 | (.00) | -0.01 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 2.83 | 0.02 | 0.13 | 0.00 | -0.01 |
| Diluted EPS (Rs.) | 2.83 | 0.00 | 0.13 | 0.00 | -0.01 |
| | | | | | |
| PBITOE Margin (%) | 11.62 | 5.13 | 6.08 | N.A | N.A |
| PBTE Margin (%) | 11.62 | 11.49 | 6.08 | N.A | N.A |
| PBT Margin (%) | 11.62 | 11.49 | 6.08 | N.A | N.A |
| PAT Margin (%) | 8.70 | 9.82 | 6.08 | N.A | N.A |